Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism

Authors

Alison M. Goate, Washington University School of Medicine in St. Louis
Carlos Cruchaga, Washington University School of Medicine in St. Louis
et al

Journal

Acta Neuropathologica

Publication Date

2017

Volume

133

Issue

6

Inclusive Pages

955-966

Document Type

Open Access Publication

DOI

10.1007/s00401-016-1652-z

Rights and Permissions

Chapuis, J., Flaig, A., Grenier-Boley, B. et al. Acta Neuropathol (2017) 133: 955. https://doi.org/10.1007/s00401-016-1652-z © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Recommended Citation

Goate, Alison M.; Cruchaga, Carlos; and et al, "Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism." Acta Neuropathologica. 133, 6. 955-966. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6421